Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Coronavirus (COVID-19) and Medical Devices

Coronavirus (COVID-19) and Medical Devices

                        At-Home OTC COVID-19 Diagnostic Tests
          Counterfeit At-Home OTC COVID-19 Diagnostic Tests
          At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions
          Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers
          COVID-19 Tests Granted Traditional Marketing Authorization by the FDA
          Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19
          Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA)
          Contacts for Medical Devices Related to COVID-19 Home
          Medical Devices
          Medical Device Safety
          Emergency Situations (Medical Devices)
          Coronavirus (COVID-19) and Medical Devices
          Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA)Coronavirus (COVID-19) and Medical Devices Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA)
  
  	
    Share
    Post
    Linkedin

    Email
    Print**May 12, 2023** – The COVID-19 public health emergency (PHE) declared under section 319 of the Public Health Service (PHS) Act expired on May 11, 2023.

The end of the PHE under section 319 of the PHS Act does not impact the FDA’s ability to authorize devices, including tests, for emergency use. Existing emergency use authorizations (EUAs) for devices remain in effect and the FDA may continue to issue new EUAs going forward while the EUA declarations under section 564 of the Federal Food, Drug, and Cosmetic Act are in effect and when the criteria for issuance of an EUA are met. Additional information is provided on the page FAQs: What happens to EUAs when a public health emergency ends?


This page answers questions about adverse event reporting for medical devices distributed under Emergency Use Authorizations (EUAs) and points out a number of adverse event reporting-related resources.

**Q: What are the adverse event reporting requirements for manufacturers of medical devices under an EUA?**

A: Each Emergency Use Authorization (EUA) includes Conditions of Authorization that specify the adverse event reporting requirements for authorized devices. Generally, each EUA includes a condition that the EUA holder follow the reporting requirements in 21 CFR Part 803. Manufacturers should refer to their EUA letter for a given authorized device for the particular reporting requirements.  MDRs for EUA devices can be submitted via the same mechanisms used for non-EUA devices.

Medical device reporting under 21 CFR Part 803 generally requires reporting of deaths, serious injuries, and malfunctions that have, may have, or would be likely to cause or contribute to a death or serious injury. For more information regarding adverse event reporting for authorized medical devices, please refer to Section III.E.2 of the FDA guidance document, Emergency Use Authorization of Medical Products and Related Authorities. General information about reporting MDRs under 21 CFR Part 803 can be found on FDA’s webpage: Mandatory Reporting Requirements: Manufacturers, Importers and Device User Facilities.

**Q: How do manufacturers submit an MDR for their medical devices?**

A: FDA has established an Electronic Medical Device Reporting (eMDR) system, as described in FDA’s guidance document, Questions and Answers about eMDR - Electronic Medical Device Reporting. Submission of MDRs using the eMDR system involves creating an account capable of submitting reports to the FDA-wide Electronic Submissions Gateway and the completion of FDA Form 3500Ain electronic format to capture the event information.

As part of creating an eMDR gateway account for submitting MDRs, a device establishment typically provides the FDA Establishment Identifier (FEI) number received as part of the Registration and Listing process. In some instances, FEI numbers are created outside of the Registration and Listing process. To retrieve an FEI number assigned to your device establishment, you may visit the FEI Search Portal. If an FEI has not been previously assigned, you can request an FEI number by email (see below).

Also see the question below, ***Q: What product codes should be used when preparing adverse event reports for these products?***, for more information on what to include in the MDR.

**Q: How does a device establishment create an eMDR account if it is not required to register and list?**

A: If your device establishment is not required to register and list, but you are seeking to submit MDRs for a device available, you can request an FEI number by email to feiportal@fda.hhs.gov by including the following information:

Device establishment name and address
	Device Owner Operator number (if known)
	Establishment type
	Device panel
	Official correspondent name, email, and telephone number
	U.S. Agent name, email, and telephone number (for foreign device establishments)There is no cost associated with requesting an FEI number. Before requesting an FEI number, device establishments should check theFEI Search Portalto ensure a number has not already been assigned to them.

Creating an FEI number in this way is not a substitute for Registration and Listing and does not satisfy any Registration and Listing requirements.  Device establishments wishing to register and list should follow the Registration and Listingprocess listed on the FDA website.

For more information regarding the electronic submission of MDRs, please refer to the FDA guidance document, Questions and Answers about eMDR - Electronic Medical Device Reporting. In addition, see eMDR – Electronic Medical Device Reporting for details on how to set up an account for submitting these reports.

**Q: What are the specified time frames for submitting MDRs?**

A: According to the Code of Federal Regulations, 21 CFR Part 803, manufacturers must submit MDRs to the FDA no later than 30 calendar days after becoming aware of the reportable event, or within 5 calendar days for events necessitating remedial action to prevent a risk of substantial harm to the public health.

**Q: The FDA issued a guidance document, Guidance for Industry: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic. Do the adverse event reporting recommendations in this guidance document apply to medical devices under EUA?**

A: The guidance does not apply to medical devices under EUA. Page 2 of the guidance states that, “... this guidance does not address monitoring and reporting of adverse events that might be imposed as a condition for medical products authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360bbb-3).” The EUAs issued for medical devices related to COVID-19 all include Conditions of Authorization for adverse event reporting.

**Q: What are the reporting expectations for patients, health care professionals, and consumers using medical devices under EUA?**

A: Patients, health care professionals, and consumers who experience a problem with a medical device under an EUA are encouraged to report these problems to the FDA. These reports can provide important safety information that complements information submitted by manufacturers. Such reports can be submitted to the FDA through MedWatch, the FDA Safety Information and Adverse Event Reporting Program, using the following methods:

Complete the MedWatch Online Reporting Form
	Download form or call 1-800-332-1088 to request a reporting form, and complete and return to the address on the pre-addressed form.**Q: What product codes are to be used when preparing adverse event reports for devices authorized under an EUA?**

A: When submitting MDRs, the product code is used to ensure the MDR can be appropriately analyzed and reduce the need for follow-up from the FDA.  Medical devices for COVID-19 that have been granted an EUA and their respective product codes are listed on the Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices web page.

The list below includes product codes for some of the medical devices that are currently authorized under EUAs:

**Device Types**

In Vitro Diagnostics EUAs
	Blood Purification Devices EUAs
	Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs
	Infusion Pump EUAs
	Personal Protective Equipment EUAs
	Remote or Wearable Patient Monitoring Devices EUAs
	Respiratory Assist Devices EUAs
	Ventilators and Ventilator Accessories EUAs**Q: Whom should I contact if I have any questions about adverse event reporting for my medical device?**

A: If you have a general question related to adverse event reporting for medical devices under EUA, send an email to COVID19-DeviceReporting@fda.hhs.gov.

                                                                                  Content current as of:
      05/12/2023
              
              
Regulated Product(s)
		 Medical DevicesHealth Topic(s)
			  CoronavirusCoronavirus (COVID-19) and Medical Devices

          
                        At-Home OTC COVID-19 Diagnostic Tests
          Counterfeit At-Home OTC COVID-19 Diagnostic Tests
          At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions
          Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers
          COVID-19 Tests Granted Traditional Marketing Authorization by the FDA
          Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19
          Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA)
          Contacts for Medical Devices Related to COVID-19
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop